GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

DENTSPLY SIRONA XRAY · USD

Health Care · US listing · 🇺🇸 United States

Compare

9.54

+0.85%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$3.68bn

FY2016FY2025

Net income

−$598.0m

FY2016FY2025

Free cash flow

$104.0m

FY2016FY2025

Shareholders' equity

$1.34bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$3.68bn$3.79bn$3.96bn$3.92bn$4.23bn$3.34bn$4.02bn$3.99bn$3.99bn$3.75bn
Gross profit$1.84bn$1.96bn$2.09bn$2.13bn$2.35bn$1.66bn$2.16bn$2.07bn$2.19bn$2.00bn
Research and development$150.0m$165.0m$184.0m$174.0m$171.0m$123.0m$143.0m$160.5m$151.7m$128.5m
Operating income$252.0m−$867.0m−$85.0m−$937.0m$608.0m−$4.0m$353.0m−$916.1m−$1.57bn$454.7m
Net income−$598.0m−$910.0m−$132.0m−$950.0m$411.0m−$73.0m$256.0m−$1.01bn−$1.55bn$429.9m
Diluted earnings per share-3.00-4.48-0.63-4.421.88-0.331.15-4.52-6.781.84

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$5.43bn$5.75bn$7.37bn$7.64bn$9.24bn$9.35bn$8.60bn$8.69bn$10.38bn$11.66bn
Cash and short-term investments$326.0m$272.0m$334.0m$365.0m$339.0m$438.0m$405.0m$309.6m$320.6m$383.9m
Total liabilities$4.09bn$3.81bn$4.08bn$3.83bn$4.24bn$4.42bn$3.51bn$3.55bn$3.74bn$3.53bn
Debt$2.38bn$2.13bn$2.12bn$1.94bn$2.10bn$2.28bn$1.44bn$1.66bn$1.64bn$1.53bn
Shareholders' equity$1.34bn$1.94bn$3.29bn$3.81bn$5.00bn$4.93bn$5.09bn$5.12bn$6.64bn$8.13bn
Shares outstanding200m203m211m215m219m220m224m224m229m234m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$235.0m$461.0m$377.0m$517.0m$657.0m$635.0m$632.8m$499.8m$601.9m$563.4m
Capital spending−$131.0m−$180.0m−$149.0m−$149.0m−$142.0m−$87.0m−$122.9m−$188.0m−$151.0m−$126.1m
Free cash flow$104.0m$281.0m$228.0m$368.0m$515.0m$548.0m$509.9m$311.8m$450.9m$437.3m
Dividends paid−$128.0m−$126.0m−$116.0m−$104.0m−$92.0m−$88.0m−$80.9m−$78.6m−$78.3m−$64.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$898.0m$880.0m$961.0m$904.0m$936.0m$879.0m$905.0m$951.0m
Gross profit$493.0m$427.0m$443.0m$441.0m$490.0m$466.0m$446.0m$495.0m
Operating income$82.0m$30.0m$268.0m$46.0m−$129.0m$63.0m−$507.0m−$460.0m
Net income$37.0m−$10.0m−$146.0m−$427.0m−$45.0m$20.0m−$430.0m−$494.0m
Diluted earnings per share0.18-0.05-0.73-2.14-0.230.10-2.12-2.43
Cash from operations$99.0m$40.0m$101.0m$79.0m$48.0m$7.0m$87.0m$141.0m
Capital spending−$44.0m−$52.0m−$41.0m−$39.0m−$32.0m−$19.0m−$51.0m−$43.0m
Free cash flow$55.0m−$12.0m$60.0m$40.0m$16.0m−$12.0m$36.0m$98.0m
Total assets$5.20bn$5.23bn$5.43bn$5.65bn$6.07bn$6.05bn$5.75bn$6.63bn
Cash and short-term investments$239.0m$190.0m$326.0m$363.0m$359.0m$398.0m$272.0m$296.0m
Debt$2.22bn$2.24bn$2.38bn$2.40bn$2.40bn$2.33bn$2.18bn$2.22bn
Shareholders' equity$1.35bn$1.32bn$1.34bn$1.48bn$1.96bn$2.01bn$1.94bn$2.49bn

Financial ratios

Data as of 26 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin50.0%51.6%52.6%54.2%55.5%49.6%
Operating margin-10.8%-22.9%-2.4%-25.2%14.3%-0.1%
Net margin-16.3%-24.0%-3.3%-24.2%9.7%-2.2%
Return on equity-44.6%-46.9%-4.0%-24.9%8.2%-1.5%
Return on assets-11.0%-15.8%-1.8%-12.4%4.4%-0.8%
Free cash flow yield19.4%33.5%26.4%32.8%38.7%34.9%
Revenue growth-3.0%-4.3%1.1%-7.3%26.7%-17.0%
Earnings growth-34.3%589.4%-86.1%-331.1%-663.0%-128.5%
Current ratio1.51x1.10x1.38x1.62x1.47x1.31x
Debt to equity1.77x1.12x0.66x0.52x0.43x0.47x
Equity ratio24.7%33.8%44.7%49.9%54.1%52.7%
Interest coverage-4.52x-12.57x-1.16x-15.23x9.93x-0.06x
R&D as a share of sales4.1%4.4%4.6%4.4%4.0%3.7%
Buybacks as a share of market value1.8%3.7%2.0%1.9%0.1%1.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.1%2.0%3.2%
Operating income——-3.9%
Net income-14.3%52.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.8%52.2%52.4%53.1%
Operating margin-8.2%-10.7%-4.5%-5.6%
Net margin-20.2%-16.9%-9.8%-9.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-3.8-4.2-56.9-7.229.8-157.449.4-8.2-9.731.4
Price to sales0.61.01.91.82.93.43.12.13.83.6

Market value over time

30 Nov 2016 to 23 Oct 2026, in USD

$13.75bn$1.89bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-40%-46%13%-42%0%-8%60%-46%10%2%

Dividends and splits

Per share, in the currency the company pays

Paid for 32 years. Last went ex-dividend on 26 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.640.640.560.500.430.400.3750.35
  • 2-for-1 split · 18 Jul 2006
  • 3-for-2 split · 1 Feb 2002
  • 2-for-1 split · 30 Oct 1997
  • 2-for-1 split · 24 Aug 1992

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.